Wuhu Interferon Bio-products Industry Research Institute Co., Ltd. was established in December 2015 with a registered capital of 50 million yuan. It is a new product research and development-oriented technology-based enterprise. With core technologies in the fields of genetic engineering recombinant proteins and cell biology, Interferon has developed a complete series of second-generation long-acting interferon and cytokine immune enhancers for animals, as well as a series of biological protein feed additives that replace antibiotics. Interferon is supported by all-round technical support of the biomedical engineering center jointly built by the central and local Anhui Medical University. Its main business scope is the development and application of various biological proteins. Diagnostic reagents and scientific research reagents, core proteins and other production technologies.

Currently, Interferon has set up a "one hospital and three places" R&D center layout: Wuhu area has nearly 6,000 square meters of biological skin care functional protein R&D and production platform built in accordance with GMP standards, and has introduced a full set of fermentation production equipment system from Sartorius from Germany and GE from the United States. Protein purification production equipment system; Hefei Regional R&D Center was designed by Wuhan Institute of Virology, Chinese Academy of Sciences in accordance with the standards of world-class biological protein engineering centers. Anhui Province invested 30 million yuan, and Hefei Vocational and Technical College provided 3,000 square meters of housing, which was constructed in strict accordance with drug GMP requirements. , has been completed and is in the process of equipment debugging. The three parties jointly built, our company is responsible for the daily R&D and operation of the engineering center; the central and local biomedical engineering center of Anhui Medical University in Hefei area (Hefei) was constructed in 2008, relying on the 42-year research on interferon and other biological proteins by the Microbiology Teaching and Research Department of Anhui Medical University Background, affiliated with the State Key Laboratory of Dermatology, key disciplines, and key clinical specialties.

Interferon has a core technology research and development team consisting of masters and doctors in the fields of microbiology, cell biology, molecular biology, and animal medicine. The team has successively undertaken more than ten scientific research projects such as the "Thirteenth Five-Year Plan" national key research and development plan, published 18 SCI papers, obtained 12 invention patents (more than 30 are being declared), won the second prize of Anhui Provincial Science and Technology Progress Award, and Anhui Invention He has won more than 10 important awards, including the Silver Award for Patents, the Second Prize of China Innovation Competition, and the Gold Award for Invention and Entrepreneurship of China Invention Association, and has completed the development and transfer of a number of biological drugs. The company has been approved successively in recent years: the first batch of new R&D institutions of the Anhui Provincial Department of Science and Technology, the Engineering Laboratory of the Anhui Provincial Development and Reform Commission, the Wuhu City Key Industry Research Institute, the Wuhu City Introduced High-level Talent Team, and the Wuhu City Biological Protein Development and Application Engineering Technology Center, etc. title.

In 2021, Interferon will create its own medical and beauty brands: Hao Lianna, Wan Yanyu, and Punoting. Currently, it has established long-term and stable cooperative relations with many well-known domestic and foreign companies and institutions. Interferon will uphold honesty and dedication. , enterprising and innovative core values, with the mission of providing high-quality products and services for the biotechnology, biomedicine, and medical beauty industries.